Rock Springs Capital Management LP Horizon Therapeutics Public LTD CO Transaction History

Rock Springs Capital Management LP

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 14, 2023	SELL	$98.98 - $115.74 $23.7 Million - $27.7 Million	-239,500 Reduced 48.38%	255,500 $29.6 Million
Q2 2023 Aug 14, 2023	SELL	$96.34 - $112.38 $23.6 Million - $27.5 Million	-245,100 Reduced 33.12%	495,000 $50.9 Million
Q1 2023 May 15, 2023	BUY	$107.32 - $113.5 $42,928 - $45,400	400 Added 0.05%	740,100 $80.8 Million
Q4 2022 Feb 14, 2023	BUY	$62.39 - $113.8 $792,353 - $1.45 Million	12,700 Added 1.75%	739,700 $84.2 Million
Q3 2022 Nov 14, 2022	SELL	$58.92 - $84.67 $1.12 Million - $1.61 Million	-19,000 Reduced 2.55%	727,000 $45 Million

Q4 2021 Feb 14, 2022	BUY	$98.56 - $119.91 $4.34 Million - $5.28 Million	44,000 Added 6.27%	746,000 $80.4 Million
Q3 2021 Nov 15, 2021	BUY	$91.91 - $110.37 $7.08 Million - $8.5 Million	77,000 Added 12.32%	702,000 $76.9 Million
Q4 2020 Feb 16, 2021	SELL	$67.0 - $84.39 $1.68 Million - $2.11 Million	-25,000 Reduced 3.85%	625,000 $45.7 Million
Q3 2020 Nov 16, 2020	BUY	$55.23 - $79.93 $35.9 Million - $52 Million	650,000 New	650,000 $50.5 Million

2.07M

20K

Ticker HZNP
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 230,384,000
Description
Horizon Therapeutics Public Limited Company, a biotechnology company, focuses on the discovery, development, and commercialization of medicines that address critical needs for people impacted by rare, autoimmune, and severe inflammatory diseases. The company operates in two segments, Orphan and Inflammation. Its portfolio comprises 12 medicines ...

Get notified when there are updates to the investment portfolio of Rock Springs Capital Management LP, based on Form 13F filings with the SEC.

Stay updated on Rock Springs Capital Management LP with notifications on news.